Cesarean Section
Conditions
Interventions
B group:bupivacaine 9 mg (1.5 ml) i,t.
BF group:bupivacai7.5 mg+ fentanal 20 ug i.t.
BD group:bupivacaine 7.5mg + dexmedetomidine 5ug i.t.
Sponsors
Feng Xian People's Hospital
Eligibility
Sex/Gender
Female
Age
20 Years to 36 Years
Inclusion criteria
Inclusion criteria: puerpera with history of cardiac, respiratory, hepatic or renal disease, long history of taking analgetics or sedative, pregnant complications, with contraindications for spinal anesthesia, allergy to the study drugs, Participation in other drugs clinical trials during the past 3 months.
Exclusion criteria
Exclusion criteria: puerpera with history of cardiac, respiratory, hepatic or renal disease, long history of taking analgetics or sedative, pregnant complications, with contraindications for spinal anesthesia, allergy to the study drugs, Participation in other drugs clinical trials during the past 3 months.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| concentration of dexmedetomidine in maternal blood;concentration of dexmedetomidine in fetal umbilical cord blood; | — |
Secondary
| Measure | Time frame |
|---|---|
| vital sign;adverse reaction;comfortable level of puerpera;the onset and offset time of spinal anesthesia;VAS score of analgesia;apgar score of neonatal; | — |
Countries
China
Contacts
Public ContactLi Yumei
Affiliated hospital of Xuzhou medical university
Outcome results
None listed